![Peter Würtz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 15 258 $ au 31/10/2024
Peter Würtz was the founder of Nightingale Health Oyj, founded in 2002, holding the title of Scientific Director.
Dr. Würtz holds a doctorate from the University of Helsinki.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 15 228 ( 0,04% ) | 15 247 $ | 31/05/2026 | |
| 31/12/2025 | 1 126 342 ( 1,85% ) | 11 $ | 31/10/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| NIGHTINGALE HEALTH OYJ | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
University of Helsinki
 University of Helsinki Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nightingale Health Oyj
 Nightingale Health Oyj Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology for improving risk prediction of diseases such as cardiovascular diseases and diabetes | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
